These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. The effect of peritonitis on the transperitoneal transport of cefuroxime in patients on CAPD treatment. Dahl K; Walstad RA; Widerøe TE Nephrol Dial Transplant; 1990; 5(4):275-81. PubMed ID: 2113224 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis. Whitby M; Edwards R; Aston E; Finch RG J Antimicrob Chemother; 1987 Mar; 19(3):351-7. PubMed ID: 3571051 [TBL] [Abstract][Full Text] [Related]
35. [Pharmacokinetics of cefotiam in patients undergoing continuous ambulatory peritoneal dialysis]. Itagaki N; Hasegawa H; Tsujino M; Takahashi K; Yamamoto Y; Imada A; Horiuchi A Jpn J Antibiot; 1988 Apr; 41(4):405-8. PubMed ID: 3165474 [TBL] [Abstract][Full Text] [Related]
36. Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients. Bastani B; Freer K; Read D; Bailey S; Sherman RA; Davis M; Engels D; Westervelt FB Nephron; 1987; 45(4):283-5. PubMed ID: 3587467 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysis. Debruyne D; Ryckelynck JP; Moulin M; Hurault de Ligny B; Levaltier B; Bigot MC Clin Pharmacokinet; 1990 Jun; 18(6):491-8. PubMed ID: 2354592 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis. Dahl NV; Foote EF; Searson KM; Fein JL; Kapoian T; Steward CA; Sherman RA Ann Pharmacother; 1998 Dec; 32(12):1284-9. PubMed ID: 9876807 [TBL] [Abstract][Full Text] [Related]
39. Intraperitoneal production of erythropoietin with continuous ambulatory peritoneal dialysis. Chandra M; Clemons G; Sahdev I; McVicar M; Bluestone P Pediatr Nephrol; 1993 Jun; 7(3):281-3. PubMed ID: 8518099 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of 300 mg/d Intraperitoneal Daptomycin: New Insight from the DaptoDP Study. Saint Paul LP; Ficheux M; Debruyne D; Loilier M; Bouvier N; Morello R; Verdon R; Le Blanc E; Cattoir V; Lobbedez T Perit Dial Int; 2018; 38(6):463-466. PubMed ID: 30413641 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]